Celsense

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Ohanlonc3 (talk | contribs) at 20:35, 12 February 2022. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Celsense, Inc. is a privately held biotechnology company offering pre-clinical and clinical-grade imaging agents used to non-invasively detect, identify, quantify, and monitor cells and cellular activity. The company is based in Pittsburgh, Pennsylvania. It was founded in 2005 to commercialize imaging platforms developed at Carnegie Mellon University. The company ceased operations on December 31, 2021.